Nexalin NeuroCare

Nexalin Technology is a medical device and digital health company that designs and develops non-invasive neurostimulation products to treat mental health and neurological disorders. The company's proprietary Deep Intracranial Frequency Stimulation (DIFS) technology delivers advanced frequency-based stimulation waveforms to penetrate deep brain structures, such as the midbrain and hypothalamus, to normalize brain chemistry without drugs or side effects. Nexalin's product ecosystem includes the Gen-2 clinical console, the Gen-3 HALO Clarity wearable headset, and Nexalin NeuroCare, an AI-driven virtual clinic platform that enables remote physician monitoring and at-home treatment. The company is currently advancing a pivotal clinical trial of its HALO Clarity device for moderate-to-severe insomnia to support an FDA De Novo submission, while expanding commercialization of its Gen-2 device internationally.